These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 30928770

  • 1. RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
    Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN.
    J Surg Res; 2019 Aug; 240():130-135. PubMed ID: 30928770
    [Abstract] [Full Text] [Related]

  • 2. RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score.
    Arjona-Sanchez A, Rodriguez-Ortiz L, Baratti D, Schneider MA, Gutiérrez-Calvo A, García-Fadrique A, Tuynman JB, Cascales-Campos PA, Martín VC, Morales R, Salti GI, Arteaga X, Pacheco D, Alonso-Gomez J, Yalkin O, Villarejo-Campos P, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Rufian-Peña S, Briceño J.
    Ann Surg Oncol; 2019 Aug; 26(8):2595-2604. PubMed ID: 31111351
    [Abstract] [Full Text] [Related]

  • 3. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
    Lam JY, McConnell YJ, Rivard JD, Temple WJ, Mack LA.
    Am J Surg; 2015 Sep; 210(3):424-30. PubMed ID: 26051744
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM.
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    van Eden WJ, Elekonawo FMK, Starremans BJ, Kok NFM, Bremers AJA, de Wilt JHW, Aalbers AGJ.
    Ann Surg Oncol; 2018 Jul; 25(7):1992-2001. PubMed ID: 29671139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.
    Bhullar D, O'Dwyer S, Wilson M, Saunders MP, Kochhar R, Barriuso J, Aziz O.
    Ann Surg Oncol; 2023 Feb; 30(2):792-801. PubMed ID: 36400886
    [Abstract] [Full Text] [Related]

  • 10. Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis.
    Gao Z, Qi X, Wang R, Wen Z, Qi H, Ju M, Liu X, Wang J, Zhou H, Zhu Z, Liu X, Li K.
    Eur J Surg Oncol; 2024 Sep; 50(9):108474. PubMed ID: 38870874
    [Abstract] [Full Text] [Related]

  • 11. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study.
    Burnett A, Lecompte MA, Trabulsi N, Dubé P, Gervais MK, Trilling B, Cloutier AS, Sideris L.
    World J Surg Oncol; 2019 May 15; 17(1):83. PubMed ID: 31092250
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.
    Lee L, Alie-Cusson F, Dubé P, Sideris L.
    J Surg Oncol; 2017 Aug 15; 116(2):236-243. PubMed ID: 28409831
    [Abstract] [Full Text] [Related]

  • 15. Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin.
    Schneider MA, Eden J, Pache B, Laminger F, Lopez-Lopez V, Steffen T, Hübner M, Kober F, Roka S, Campos PC, Roth L, Gupta A, Siebenhüner A, Kepenekian V, Passot G, Gertsch P, Glehen O, Lehmann K.
    Ann Surg; 2018 Nov 15; 268(5):845-853. PubMed ID: 30303876
    [Abstract] [Full Text] [Related]

  • 16. Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Tonello M, Baratti D, Sammartino P, Di Giorgio A, Robella M, Sassaroli C, Framarini M, Valle M, Macrì A, Graziosi L, Coccolini F, Lippolis PV, Gelmini R, Deraco M, Biacchi D, Santullo F, Vaira M, Di Lauro K, D'Acapito F, Carboni F, Giuffrè G, Donini A, Fugazzola P, Faviana P, Sorrentino L, Scapinello A, Del Bianco P, Sommariva A.
    Ann Surg Oncol; 2022 Jun 15; 29(6):3405-3417. PubMed ID: 34783946
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Solomon D, DeNicola NL, Feferman Y, Bekhor E, Reppucci ML, Feingold D, Aycart SN, Magge DR, Golas BJ, Labow DM, Sarpel U.
    Ann Surg Oncol; 2019 Mar 15; 26(3):845-851. PubMed ID: 30643994
    [Abstract] [Full Text] [Related]

  • 19. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Jimenez W, Sardi A, Nieroda C, Sittig M, Milovanov V, Nunez M, Aydin N, Gushchin V.
    Ann Surg Oncol; 2014 Dec 15; 21(13):4218-25. PubMed ID: 24986239
    [Abstract] [Full Text] [Related]

  • 20. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Braam HJ, van Oudheusden TR, de Hingh IH, Nienhuijs SW, Boerma D, Wiezer MJ, van Ramshorst B.
    J Surg Oncol; 2014 Jun 15; 109(8):841-7. PubMed ID: 24619813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.